Organisms | Evidence |
---|---|
Ovis aries (sheep) | |
Cricetulus griseus (Chinese hamster) | |
Mus musculus (house mouse) | |
Bos taurus (domestic cattle) | |
Escherichia coli |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | (not applicable) |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
Ser/Thr |
|
Ser/Thr | |
ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
C1GALT1 | UDP-Gal |
|
PSGL-1(EYEYLDYDFLPETEPPEM) |
|
PSGL-1(EYEYLDYDFLPETEPPEM) | |
C1GALT1 | UDP-Gal |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
B3GNT6 | UDP-GlcNAc |
|
[alpha]-pNP |
|
[alpha]-pNP |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
---|---|---|---|---|
ST6GALNAC3 | CMP-Neu5Ac |
|
Ser/Thr | |
ST6GAL2 | CMP-Neu5Ac |
|
para-nitrophenol | |
ST6GALNAC2 | CMP-Neu5Ac |
|
benzyl | |
ST6GALNAC1 | CMP-Neu5Ac |
|
[alpha]-Bz | |
ST6GALNAC2 | CMP-Neu5Ac |
|
Ser/Thr |
UniProt ID | Protein Name | Reference | Source |
---|---|---|---|
Q9UKP4 | A disintegrin and metalloproteinase with thrombospondin motifs 7 | ||
Q9UKU9 | Angiopoietin-related protein 2 | ||
Q9ULB5 | Cadherin-7 | ||
Q9ULC8 | Palmitoyltransferase ZDHHC8 | ||
Q9ULF5 | Zinc transporter ZIP10 | ||
Q9ULI3 | Protein HEG homolog 1 | ||
Q9UMD9 | Collagen alpha-1(XVII) chain | ||
Q9UMX5 | Neudesin | ||
Q9UNA0 | A disintegrin and metalloproteinase with thrombospondin motifs 5 | ||
Q9UNE0 | Tumor necrosis factor receptor superfamily member EDAR |
Pathway Name | Organism |
---|---|
E.coli O101 | Escherichia coli |
E.coli O103 | Escherichia coli |
E.coli O107 | Escherichia coli |
E.coli O112ab | Escherichia coli |
E.coli O112ac | Escherichia coli |
E.coli O116 | Escherichia coli |
E.coli O117 | Escherichia coli |
E.coli O125ab | Escherichia coli |
E.coli O127 | Escherichia coli |
E.coli O128ab-H27 | Escherichia coli |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
33246621 | Large-scale preparation and glycan characterization of sialylglycopeptide from bovine milk glycomacropeptide and its bifidogenic properties | Fukudome H | 2021 Feb |
|
34468210 | Programmed Instability of Ligand Conjugation Manifold for Efficient Hepatocyte Delivery of Therapeutic Oligonucleotides | Terada C | 2021 Dec 01 |
|
34645280 | N-Acetyl Galactosamine Targeting: Paving the Way for Clinical Application of Nucleotide Medicines in Cardiovascular Diseases | Biessen EAL | 2021 Dec |
|
34037271 | Clinical Study of Single‐Stranded Oligonucleotide RO7062931 in Healthy Volunteers and Patients With Chronic Hepatitis B | Gane E | 2021 Aug 25 |
|
34353949 | A noncoding RNA modulator potentiates phenylalanine metabolism in mice | Li Y | 2021 Aug 06 |
|
33861634 | Impact of Serum Proteins on the Uptake and RNAi Activity of GalNAc-Conjugated siRNAs | Agarwal S | 2021 Aug 01 |
|
34344029 | [New therapeutic option for acute hepatic porphyrias] | Stölzel U | 2021 Aug |
|
33871817 | Givosiran: A Review in Acute Hepatic Porphyria | Syed YY | 2021 Apr 19 |
|
33639525 | Metabolomic profiling reveals plasma GlycA and GlycB as a potential biomarkers for treatment efficiency in rheumatoid arthritis | Dudka I | 2021 Apr 15 |
|
33928570 | Development of siRNA Therapeutics for the Treatment of Liver Diseases | Holm A | 2021 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025